Abstract | INTRODUCTION: The dysfunction of glycogen synthase kinase-3β (GSK-3β) has been implicated in a number of diseases, including Alzheimer's disease. The ability to non-invasively quantify GSK-3β activity in vivo is therefore of critical importance, and this work is focused upon development of inhibitors of GSK-3β radiolabeled with carbon-11 to examine quantification of the enzyme using positron emission tomography (PET) imaging. METHODS: (11)C PyrATP-1 was prepared from the corresponding desmethyl- piperazine precursor in an automated synthesis module. In vivo rodent and primate imaging studies were conducted on a Concorde MicroPET P4 scanner to evaluate imaging properties and in vitro autoradiography studies with rat brain samples were carried out to examine specific binding. RESULTS: 2035±518MBq (55±14mCi) of [(11)C]PyrATP-1 was obtained (1%-2% non-corrected radiochemical yield at end-of-synthesis based upon [(11)C]CO2) with high chemical (>95%) and radiochemical (>99%) purities, and good specific activities (143±52GBq/μmol (3874±1424Ci/mmol)), n=5. In vivo microPET imaging studies revealed poor brain uptake in rodents and non-human primates. Pretreatment of rodents with cyclosporin A resulted in moderately increased brain uptake suggesting Pgp transporter involvement. Autoradiography demonstrated high levels of specific binding in areas of the rodent brain known to be rich in GSK-3β. CONCLUSION: (11)C PyrATP-1 is readily synthesized using standard carbon-11 radiochemistry. However the poor brain uptake in rodents and non-human primates indicates that the radiotracer is not suitable for the purposes of quantifying GSK-3β in neurological and psychiatric disorders.
|
Authors | Erin L Cole, Xia Shao, Phillip Sherman, Carole Quesada, Maria V Fawaz, Timothy J Desmond, Peter J H Scott |
Journal | Nuclear medicine and biology
(Nucl Med Biol)
Vol. 41
Issue 6
Pg. 507-12
(Jul 2014)
ISSN: 1872-9614 [Electronic] United States |
PMID | 24768148
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2014 Elsevier Inc. All rights reserved. |
Chemical References |
- Carbon Radioisotopes
- Protein Kinase Inhibitors
- PyrATP-1
- Pyrazines
- Radioactive Tracers
- Sulfonamides
- Pyrazinamide
- Glycogen Synthase Kinase 3
|
Topics |
- Animals
- Brain
(diagnostic imaging)
- Carbon Radioisotopes
- Chemistry Techniques, Synthetic
- Female
- Glycogen Synthase Kinase 3
(antagonists & inhibitors, metabolism)
- Positron-Emission Tomography
(methods)
- Protein Kinase Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Pyrazinamide
(analogs & derivatives, chemical synthesis, chemistry, pharmacology)
- Pyrazines
(chemical synthesis, chemistry, pharmacology)
- Radioactive Tracers
- Radiochemistry
- Rats
- Sulfonamides
(chemical synthesis, chemistry, pharmacology)
|